RecruitingNCT02798731
Physiologic Assessment of Microvascular Function in Heart Transplant Patients
Physiologic Assessment of Microvascular Function and Its Impact on Cardiac Allograft Vasculopathy in Heart Transplant Patients: Prospective Registry and Pilot Study
Sponsor
Samsung Medical Center
Enrollment
200 participants
Start Date
May 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the study is to evaluate the impact of early microvascular disease assessed by coronary physiologic indices such as fractional flow reserve (FFR), coronary flow reserve (CFR), index of microvascular resistance (IMR) on future occurrence of cardiac allograft vasculopathy (CAV) in heart transplant recipients.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria2
- Subject over age of 18
- Patients received heart transplant
Exclusion Criteria7
- Patients with cardiogenic shock
- Patients with unstable vital sign that precludes coronary angiography
- Patients with major bleeding in last 3 months
- Patients with active bleeding
- Patients with coagulopathy
- Patients with severe valvular heart disease
- Patients who refused to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02798731